<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To apply the WHO criteria and the minimal diagnostic criteria to the classification of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) with low percentage (&lt; 0.050) bone marrow (BM) blasts </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Two hundred and ten <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with less than 0.050 BM blasts diagnosed between 1988 and 2005 according to FAB criteria were retrospectively reclassified with WHO criteria (2001) and minimal diagnostic criteria </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: According to the WHO criteria, 5 patients were diagnosed as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA), 7 as <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), 76 as refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>), 9 as <z:e sem="disease" ids="C1301356" disease_type="Neoplastic Process" abbrv="">RCMD-RS</z:e>, 35 as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-unclassified (<z:e sem="disease" ids="C0854809" disease_type="Neoplastic Process" abbrv="">MDS-U</z:e>), 3 as <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q - syndromes</z:e>, and the rest 75 patients could not be classified suitably </plain></SENT>
<SENT sid="3" pm="."><plain>Among the latter 75 patients 16 BM smears showed <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in more than 2 cell lineage but only unilineage cytopenia in peripheral blood (PB) </plain></SENT>
<SENT sid="4" pm="."><plain>Nine of them were reclassified as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e> after followed up for more than half a year </plain></SENT>
<SENT sid="5" pm="."><plain>Forty-four BM smears showed erythroid <z:mpath ids='MPATH_589'>dysplasia</z:mpath> only, but bicytopenia or <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> in PB </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty-seven of them were classified as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e> after follow-up </plain></SENT>
<SENT sid="7" pm="."><plain>Fifteen BM smears not showed <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in any myeloid lineage were reclassified as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (5 patients), HS-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (5 patients) and idiopathic cytopenia of uncertain significance (ICUS) (5 patients) according to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> minimal diagnostic criteria </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: According to WHO criteria (2001), RA is the least diagnosis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The minimal diagnostic criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> classification of patients not fulfilled the standard criteria of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>